366 related articles for article (PubMed ID: 23229280)
21. Genetics of Primary Aldosteronism.
Scholl UI
Hypertension; 2022 May; 79(5):887-897. PubMed ID: 35139664
[TBL] [Abstract][Full Text] [Related]
22. Somatic and inherited mutations in primary aldosteronism.
Fernandes-Rosa FL; Boulkroun S; Zennaro MC
J Mol Endocrinol; 2017 Jul; 59(1):R47-R63. PubMed ID: 28400483
[TBL] [Abstract][Full Text] [Related]
23. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
Sertedaki A; Markou A; Vlachakis D; Kossida S; Campanac E; Hoffman DA; Sierra ML; Xekouki P; Stratakis CA; Kaltsas G; Piaditis GP; Chrousos GP; Charmandari E
Clin Endocrinol (Oxf); 2016 Dec; 85(6):845-851. PubMed ID: 27293068
[TBL] [Abstract][Full Text] [Related]
24. Familial hyperaldosteronism type III.
Monticone S; Tetti M; Burrello J; Buffolo F; De Giovanni R; Veglio F; Williams TA; Mulatero P
J Hum Hypertens; 2017 Dec; 31(12):776-781. PubMed ID: 28447626
[TBL] [Abstract][Full Text] [Related]
25. NCI-H295R cell line as in vitro model of hyperaldosteronism lacks functional KCNJ5 (GIRK4; Kir3.4) channels.
Kienitz MC; Mergia E; Pott L
Mol Cell Endocrinol; 2015 Sep; 412():272-80. PubMed ID: 25998841
[TBL] [Abstract][Full Text] [Related]
26. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.
Azizan EA; Murthy M; Stowasser M; Gordon R; Kowalski B; Xu S; Brown MJ; O'Shaughnessy KM
Hypertension; 2012 Mar; 59(3):587-91. PubMed ID: 22252394
[TBL] [Abstract][Full Text] [Related]
27. GENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism.
Monticone S; Buffolo F; Tetti M; Veglio F; Pasini B; Mulatero P
Eur J Endocrinol; 2018 Mar; 178(3):R101-R111. PubMed ID: 29348113
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary aldosteronism.
Chueh JS; Peng KY; Wu VC; Wang SM; Chan CK; Chen YM; Ke YY; Pan CY; Liao HW
J Mol Endocrinol; 2021 Sep; 67(4):203-215. PubMed ID: 34463641
[TBL] [Abstract][Full Text] [Related]
29. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
Monticone S; Hattangady NG; Nishimoto K; Mantero F; Rubin B; Cicala MV; Pezzani R; Auchus RJ; Ghayee HK; Shibata H; Kurihara I; Williams TA; Giri JG; Bollag RJ; Edwards MA; Isales CM; Rainey WE
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1567-72. PubMed ID: 22628608
[TBL] [Abstract][Full Text] [Related]
30. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
[TBL] [Abstract][Full Text] [Related]
31. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.
Scholl UI; Nelson-Williams C; Yue P; Grekin R; Wyatt RJ; Dillon MJ; Couch R; Hammer LK; Harley FL; Farhi A; Wang WH; Lifton RP
Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2533-8. PubMed ID: 22308486
[TBL] [Abstract][Full Text] [Related]
32. Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
Omata K; Satoh F; Morimoto R; Ito S; Yamazaki Y; Nakamura Y; Anand SK; Guo Z; Stowasser M; Sasano H; Tomlins SA; Rainey WE
Hypertension; 2018 Oct; 72(4):874-880. PubMed ID: 30354720
[TBL] [Abstract][Full Text] [Related]
33. Primary aldosteronism diagnostics:
Rege J; Turcu AF; Rainey WE
Gland Surg; 2020 Feb; 9(1):3-13. PubMed ID: 32206594
[TBL] [Abstract][Full Text] [Related]
34. Novel genes in primary aldosteronism.
Fischer E; Beuschlein F
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):154-8. PubMed ID: 24739312
[TBL] [Abstract][Full Text] [Related]
35. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
Oßwald A; Fischer E; Degenhart C; Quinkler M; Bidlingmaier M; Pallauf A; Lang K; Mussack T; Hallfeldt K; Beuschlein F; Reincke M
Eur J Endocrinol; 2013 Nov; 169(5):657-63. PubMed ID: 23946277
[TBL] [Abstract][Full Text] [Related]
36. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
Seccia TM; Mantero F; Letizia C; Kuppusamy M; Caroccia B; Barisa M; Cicala MV; Miotto D; Rossi GP
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2307-13. PubMed ID: 23012392
[TBL] [Abstract][Full Text] [Related]
37. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
[TBL] [Abstract][Full Text] [Related]
38. Genetics of primary aldosteronism.
Funder JW
Front Horm Res; 2014; 43():70-8. PubMed ID: 24943299
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
40. A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue.
Monticone S; Bandulik S; Stindl J; Zilbermint M; Dedov I; Mulatero P; Allgaeuer M; Lee CC; Stratakis CA; Williams TA; Tiulpakov A
J Clin Endocrinol Metab; 2015 Jan; 100(1):E114-8. PubMed ID: 25322277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]